Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LemboCAN: Lemborexant for Cannabis Use Disorder
NCT07802990Phase 2Not yet recruiting
- Sponsor
- University of Calgary
- Start
- Nov 2026
- Primary completion
- Nov 2028
- Countries
- 1
01
Overview
A Phase 2 trial of lemborexant in cannabis use disorder (CUD), sponsored by University of Calgary. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
lemborexant
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT07802990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07802990.